Literature DB >> 26141581

An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.

David Chiang1, M Cecilia Berin.   

Abstract

Allergen immunotherapy for the treatment of food allergy has been a subject of intensive study within the last 10 years. After an unsuccessful attempt with subcutaneous immunotherapy for peanut allergy, other routes with varying degrees of safety and efficacy have been tested for peanut, milk, and egg allergies. In this review, we summarize the results to date with oral immunotherapy, sublingual immunotherapy, and epicutaneous immunotherapy for the treatment of food allergy. While results of immunotherapy trials are promising, increases in efficacy are commonly associated with an increased side effect profile. There is a need for additional research beginning at the preclinical level to develop safe and effective treatments for food allergy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26141581     DOI: 10.1007/s11882-015-0536-y

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

Authors:  Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2011-11-30       Impact factor: 10.793

2.  Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Authors:  A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

3.  Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.

Authors:  A Zaleska; T Eiwegger; O Soyer; W van de Veen; C Rhyner; M B Soyka; C Bekpen; D Demiröz; A Treis; S Söllner; O Palomares; W W Kwok; H Rose; G Senti; T M Kündig; N Ozoren; M Jutel; C A Akdis; R Crameri; M Akdis
Journal:  Allergy       Date:  2014-07-12       Impact factor: 13.146

4.  Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.

Authors:  Oliver T Burton; Stephanie L Logsdon; Joseph S Zhou; Jaciel Medina-Tamayo; Azza Abdel-Gadir; Magali Noval Rivas; Kyle J Koleoglou; Talal A Chatila; Lynda C Schneider; Rima Rachid; Dale T Umetsu; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2014-07-16       Impact factor: 10.793

5.  A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

Authors:  Satya D Narisety; Pamela A Frischmeyer-Guerrerio; Corinne A Keet; Mark Gorelik; John Schroeder; Robert G Hamilton; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2014-12-18       Impact factor: 10.793

6.  Food allergy in children: results of a standardized protocol for oral desensitization.

Authors:  G Patriarca; D Schiavino; E Nucera; G Schinco; A Milani; G B Gasbarrini
Journal:  Hepatogastroenterology       Date:  1998 Jan-Feb

7.  A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy.

Authors:  Justin M Skripak; Scott D Nash; Hannah Rowley; Nga H Brereton; Susan Oh; Robert G Hamilton; Elizabeth C Matsui; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

8.  Household peanut consumption as a risk factor for the development of peanut allergy.

Authors:  Adam T Fox; Peter Sasieni; George du Toit; Huma Syed; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

Review 9.  Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis.

Authors:  Alfredo J Lucendo; Angel Arias; José M Tenias
Journal:  Ann Allergy Asthma Immunol       Date:  2014-09-10       Impact factor: 6.347

10.  Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

Authors:  Alison M Hofmann; Amy M Scurlock; Stacie M Jones; Kricia P Palmer; Yuliya Lokhnygina; Pamela H Steele; Janet Kamilaris; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2009-05-27       Impact factor: 10.793

View more
  4 in total

1.  Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow's Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells.

Authors:  Marlotte M Vonk; Mara A P Diks; Laura Wagenaar; Joost J Smit; Raymond H H Pieters; Johan Garssen; Betty C A M van Esch; Léon M J Knippels
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

2.  Mouse strain differences in response to oral immunotherapy for peanut allergy.

Authors:  Laura Wagenaar; Marianne W H C Bol-Schoenmakers; Giulio Giustarini; Johan Garssen; Joost J Smit; Raymond H H Pieters
Journal:  Immun Inflamm Dis       Date:  2019-03-05

3.  The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.

Authors:  Marlotte M Vonk; Laura Wagenaar; Raymond H H Pieters; Leon M J Knippels; Linette E M Willemsen; Joost J Smit; Betty C A M van Esch; Johan Garssen
Journal:  Clin Transl Allergy       Date:  2017-09-29       Impact factor: 5.871

4.  Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow's Milk Allergic Mice.

Authors:  Marlotte M Vonk; Bart R J Blokhuis; Mara A P Diks; Laura Wagenaar; Joost J Smit; Raymond H H Pieters; Johan Garssen; Léon M J Knippels; Betty C A M van Esch
Journal:  Mediators Inflamm       Date:  2019-01-16       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.